Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

0.84
Delayed Data
As of 1:08pm ET
 +0.03 / +3.70%
Today’s Change
0.71
Today|||52-Week Range
5.55
-31.71%
Year-to-Date
No recent news for Rosetta Genomics Ltd.

Today’s Trading

Previous close0.81
Today’s open0.83
Day’s range0.82 - 0.87
Volume34,923
Average volume (3 months)320,089
Market cap$14.7M
Dividend yield--
Data as of 1:08pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+3.73%
Earnings growth (this year)+21.49%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+227.65%
P/E ratio--
Price/Sales19.14
Price/Book0.63

Competitors

 Today’s
change
Today’s
% change
OXGNOXiGENE Inc-0.01-1.43%
RGBPRegen BioPharma Inc+0.00+0.98%
RXIIRxi Pharmaceuticals ...+0.01+3.46%
ENUMEnumeral Biomedical ...-0.00-1.16%
Data as of 1:27pm ET, 02/10/2016

Financials

Next reporting dateMarch 28, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$1.3M
Annual profit (last year)-$14.5M
Net profit margin-1,094.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Kenneth A. Berlin
Chief Financial Officer
Ron Kalfus
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

Partner Offers